Mendonca V, Pereira Sena P, Evangelista Dos Santos AC, Rodrigues Bonvicino C, Ashton-Prolla P, Epelman S et al (2022) Diverse mutational spectrum in the 13q14 chromosomal region in a Brazilian cohort of retinoblastoma. Exp Eye Res 224:109211. https://doi.org/10.1016/j.exer.2022.109211

Article  CAS  PubMed  Google Scholar 

Global Retinoblastoma Study G, Fabian ID, Abdallah E, Abdullahi SU, Abdulqader RA, Adamou Boubacar S et al (2020) Global retinoblastoma presentation and analysis by national income level. JAMA Oncol 6:685–695. https://doi.org/10.1001/jamaoncol.2019.6716

Article  Google Scholar 

Cruz-Galvez CC, Ordaz-Favila JC, Villar-Calvo VM, Cancino-Marentes ME, Bosch-Canto V (2022) Retinoblastoma: review and new insights. Front Oncol 12:963780. https://doi.org/10.3389/fonc.2022.963780

Article  PubMed  PubMed Central  Google Scholar 

Li N, Wang YZ, Huang DS, Zhang Y, Zhang WL, Ma JM et al (2022) Clinical analysis of 16 distant metastatic retinoblastoma cases with event-free survival. Cancer Manag Res 14:367–375. https://doi.org/10.2147/CMAR.S349035

Article  PubMed  PubMed Central  Google Scholar 

Shields CL, Fulco EM, Arias JD, Alarcon C, Pellegrini M, Rishi P et al (2013) Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Eye (Lond) 27:253–264. https://doi.org/10.1038/eye.2012.175

Article  CAS  PubMed  Google Scholar 

Tanveer S, Zafar F, Bibi H, Haroon H, Ahmad O, Iqbal MS et al (2024) Advancements in retinoblastoma treatment: unraveling the potential of intravitreal chemotherapy. Cureus 16:e53012. https://doi.org/10.7759/cureus.53012

Article  PubMed  PubMed Central  Google Scholar 

Utomo PT, Respatika D, Ardianto B, Rinonce HT, Heriyanto DS, Dibyasakti BA et al (2022) Lag time, high-risk histopathological features, metastasis, and survival interrelation in retinoblastoma: a perspective from lower-middle income country. Int J Ophthalmol 15:1994–2000. https://doi.org/10.18240/ijo.2022.12.15

Article  PubMed  PubMed Central  Google Scholar 

Kristensen LS, Jakobsen T, Hager H, Kjems J (2022) The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol 19:188–206. https://doi.org/10.1038/s41571-021-00585-y

Article  CAS  PubMed  Google Scholar 

Tao M, Zheng M, Xu Y, Ma S, Zhang W, Ju S (2021) CircRNAs and their regulatory roles in cancers. Mol Med 27:94. https://doi.org/10.1186/s10020-021-00359-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu W, Zhang Y, Yang M (2024) Emerging role of circular RNAs in the pathogenesis of retinoblastoma. Ophthalmic Res 67:51–61. https://doi.org/10.1159/000535329

Article  CAS  PubMed  Google Scholar 

Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J et al (2013) Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19:141–157. https://doi.org/10.1261/rna.035667.112

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salzman J (2016) Circular RNA expression: its potential regulation and function. Trends Genet 32:309–316. https://doi.org/10.1016/j.tig.2016.03.002

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhong Y, Du Y, Yang X, Mo Y, Fan C, Xiong F et al (2018) Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol Cancer 17:79. https://doi.org/10.1186/s12943-018-0827-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khan S, Jha A, Panda AC, Dixit A (2021) Cancer-associated circRNA-miRNA-mRNA regulatory networks: a meta-analysis. Front Mol Biosci 8:671309. https://doi.org/10.3389/fmolb.2021.671309

Article  CAS  PubMed  PubMed Central  Google Scholar 

Du J, Zhuo Y, Sun X, Nie M, Yang J, Luo X et al (2023) hsa_circ_0000285 sponging miR-582–3p promotes neuroblastoma progression by regulating the Wnt/beta-catenin signaling pathway. Open Med (Wars) 18:20230726. https://doi.org/10.1515/med-2023-0726

Article  CAS  PubMed  Google Scholar 

Centron-Broco A, Rossi F, Grelloni C, Garraffo R, Dattilo D, Giuliani A et al (2023) CircAFF1 is a circular RNA with a role in alveolar rhabdomyosarcoma cell migration. Biomedicines 11:1893. https://doi.org/10.3390/biomedicines11071893

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu X, Wan J, You X, Yang W, Zhao L (2023) Circular non-coding RNA circ_0072088 serves as a ceRNA, targeting the miR-1225–5p/WT1 axis to regulate non-small cell lung cancer cell malignant behavior. Thorac Cancer 14:1969–1979. https://doi.org/10.1111/1759-7714.14943

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu Q, Hu Y, Jiang W, Ou ZL, Yao YB, Zai HY (2024) Circ-CCT2 Activates Wnt/beta-catenin signaling to facilitate hepatoblastoma development by stabilizing PTBP1 mRNA. Cell Mol Gastroenterol Hepatol 17:175–197. https://doi.org/10.1016/j.jcmgh.2023.10.004

Article  CAS  PubMed  Google Scholar 

Sun Z, Zhang A, Hou M, Jiang T (2020) Circular RNA hsa_circ_0000034 promotes the progression of retinoblastoma via sponging microRNA-361–3p. Bioengineered 11:949–957. https://doi.org/10.1080/21655979.2020.1814670

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fu C, Wang S, Jin L, Zhang M, Li M (2021) CircTET1 inhibits retinoblastoma progression via targeting mir-492 and miR-494–3p through Wnt/beta-catenin signaling pathway. Curr Eye Res 46:978–987. https://doi.org/10.1080/02713683.2020.1843685

Article  CAS  PubMed  Google Scholar 

Zhang H, Qiu X, Song Z, Lan L, Ren X, Ye B (2022) CircCUL2 suppresses retinoblastoma cells by regulating miR-214–5p/E2F2 Axis. Anticancer Drugs 33:e218–e227. https://doi.org/10.1097/CAD.0000000000001190

Article  CAS  PubMed  Google Scholar 

Song J, Ge Y, Dong M, Guan Q, Ju M, Song X et al (2023) Molecular interplay between EIF4 family and circular RNAs in cancer: mechanisms and therapeutics. Eur J Pharmacol 954:175867. https://doi.org/10.1016/j.ejphar.2023.175867

Article  CAS  PubMed  Google Scholar 

Chan CC, Dostie J, Diem MD, Feng W, Mann M, Rappsilber J et al (2004) eIF4A3 is a novel component of the exon junction complex. RNA 10:200–209. https://doi.org/10.1261/rna.5230104

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amatya N, Garg AV, Gaffen SL (2017) IL-17 signaling: the Yin and the Yang. Trends Immunol 38:310–322. https://doi.org/10.1016/j.it.2017.01.006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koh CH, Kim BS, Kang CY, Chung Y, Seo H (2024) IL-17 and IL-21: their immunobiology and therapeutic potentials. Immune Netw 24:e2. https://doi.org/10.4110/in.2024.24.e2

Article  PubMed  PubMed Central  Google Scholar 

Zhang C, Hu J, Yu Y (2020) CircRNA is a rising star in researches of ocular diseases. Front Cell Dev Biol 8:850. https://doi.org/10.3389/fcell.2020.00850

Article  PubMed  PubMed Central  Google Scholar 

Lyu J, Wang Y, Zheng Q, Hua P, Zhu X, Li J et al (2019) Reduction of circular RNA expression associated with human retinoblastoma. Exp Eye Res 184:278–285. https:/